arrow
M

Mukul R. Jain

zydus lifesciences limited
H指数:36
被引数:4,375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dose‐ and Time‐Dependent Characterization of Doxorubicin‐Induced Podocytopathy: Defining the Transition From Functional Impairment to Structural Damage

剂量和时间依赖性对多柔比星诱导足细胞病变的表征:从功能损伤到结构损伤的过渡

2026-11-180
OAAI
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats

Saroglitazar,一种新型PPAR-α/γ激动剂,通过肝细胞UGT表达调节Wistar大鼠甲状腺激素稳态

2026-05-090
PRE
Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia

基于肽的抗PCSK9产品用于长效管理高胆固醇血症

2025-08-220
PRE
Discovery of ZYDG2: a potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes

ZYDG2的发现:一种用于治疗2型糖尿病的强效、选择性及安全的GPR40激动剂

2025-04-010
PRE
Estradiol overcomes adiponectin-resistance in diabetic mice by regulating skeletal muscle adiponectin receptor 1 expression
2022-01-019
PRE